Clover Health Investments Corp.

1.05-0.0300-2.78%Vol 2.48M1Y Perf -38.64%
Oct 3rd, 2023 16:00 DELAYED
BID1.04 ASK1.06
Open1.08 Previous Close1.08
Pre-Market- After-Market1.05
 - -  - -%
Target Price
2.05 
Analyst Rating
Hold 2.80
Potential %
95.24 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/100/100 
Value Ranking
★+     44.63
Insiders Value % 3/6/12 mo.
-/100/100 
Growth Ranking
★+     41.70
Insiders Shares Cnt. % 3/6/12 mo.
-/100/100 
Income Ranking
 —    -
Price Range Ratio 52W %
28.46 
Earnings Rating
Market Cap509.10M 
Earnings Date
6th Nov 2023
Alpha-0.06 Standard Deviation0.28
Beta2.24 

Today's Price Range

1.031.10

52W Range

0.70781.91

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
-3.57%
1 Month
-18.80%
3 Months
23.63%
6 Months
27.15%
1 Year
-38.64%
3 Years
-91.65%
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
CLOV1.05-0.0300-2.78
AAPL172.40-1.3500-0.78
GOOG133.30-1.8700-1.38
MSFT313.39-8.4100-2.61
XOM115.830.20000.17
WFC38.67-0.9400-2.37
JNJ155.340.19000.12
FB196.640.99000.51
GE107.76-1.0300-0.95
JPM142.71-1.0600-0.74
Financial StrengthValueIndustryS&P 500US Markets
1.20
1.30
0.06
0.07
-269.20
Leverage Ratio 4.90
ProfitabilityValueIndustryS&P 500US Markets
0.00
-14.60
-14.50
-
-9.88
RevenueValueIndustryS&P 500US Markets
2.58B
5.85
-
-
Earnings HistoryEstimateReportedSurprise %
Q02 2023-0.13-0.0653.85
Q01 2023-0.19-0.1521.05
Q04 2022-0.34-0.2332.35
Q03 2022-0.31-0.1648.39
Q02 2022-0.23-0.224.35
Q01 2022-0.24-0.1920.83
Q04 2021-0.26-0.44-69.23
Q03 2021-0.31-0.0874.19
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date6th Nov 2023
Estimated EPS Next Report-0.10
Estimates Count1
EPS Growth Next 5 Years %-
Volume Overview
Volume2.48M
Shares Outstanding484.86K
Shares Float371.01M
Trades Count4.85K
Dollar Volume2.62M
Avg. Volume3.60M
Avg. Weekly Volume2.08M
Avg. Monthly Volume3.07M
Avg. Quarterly Volume5.66M

Clover Health Investments Corp. (NASDAQ: CLOV) stock closed at 1.08 per share at the end of the most recent trading day (a 0% change compared to the prior day closing price) with a volume of 1.70M shares and market capitalization of 509.10M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Healthcare Plans industry, Healthcare sector and employs 458 people. Clover Health Investments Corp. CEO is Vivek Garipalli.

The one-year performance of Clover Health Investments Corp. stock is -38.64%, while year-to-date (YTD) performance is 16.19%. CLOV stock has a five-year performance of %. Its 52-week range is between 0.7078 and 1.91, which gives CLOV stock a 52-week price range ratio of 28.46%

Clover Health Investments Corp. currently has a PE ratio of -1.00, a price-to-book (PB) ratio of 1.23, a price-to-sale (PS) ratio of 0.19, a price to cashflow ratio of -, a PEG ratio of -, a ROA of -32.64%, a ROC of -103.00% and a ROE of -99.83%. The company’s profit margin is -9.88%, its EBITDA margin is -14.50%, and its revenue ttm is $2.58 Billion , which makes it $5.85 revenue per share.

Of the last four earnings reports from Clover Health Investments Corp., there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $-0.10 for the next earnings report. Clover Health Investments Corp.’s next earnings report date is 06th Nov 2023.

The consensus rating of Wall Street analysts for Clover Health Investments Corp. is Hold (2.8), with a target price of $2.05, which is +95.24% compared to the current price. The earnings rating for Clover Health Investments Corp. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Clover Health Investments Corp. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Clover Health Investments Corp. has a Sell technical analysis rating based on Technical Indicators (ADX : 37.19, ATR14 : 0.07, CCI20 : -65.73, Chaikin Money Flow : -0.29, MACD : -0.05, Money Flow Index : 22.79, ROC : -4.42, RSI : 38.54, STOCH (14,3) : 10.71, STOCH RSI : 0.13, UO : 34.44, Williams %R : -89.29), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Clover Health Investments Corp. in the last 12-months were: Garipalli Vivek (Sold 0 shares of value $0 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
1 (20.00 %)
1 (20.00 %)
1 (20.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
3 (60.00 %)
3 (60.00 %)
3 (60.00 %)
Moderate Sell
1 (20.00 %)
1 (20.00 %)
1 (20.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingHold
2.80
Hold
2.80
Hold
2.80

Clover Health Investments Corp.

Clover Health Investments Corp is a healthcare technology company. It uses its proprietary technology platform to collect, structure, and analyze health and behavioral data to improve medical outcomes and lower costs for patients.

CEO: Vivek Garipalli

Telephone: +1 201 432-2133

Address: 725 Cool Springs Boulevard, Franklin 37067, TN, US

Number of employees: 458

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

56%44%

Bearish Bullish

57%43%

Bearish Bullish

55%45%

 

TipRanks News for CLOV

Wed, 09 Aug 2023 13:40 GMT Unusually active option classes on open August 9th

- TipRanks. All rights reserved.

News

Stocktwits